ArticleFrontiers in endocrinology2022

The Leydig cell biomarker INSL3 as a predictor of age-related morbidity: Findings from the EMAS cohort.

Richard Ivell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.